Patents Assigned to GLYTECH, LLC
  • Formulations for treatment of post-traumatic stress disorder
    Patent number: 10881665
    Abstract: Provided herein are compositions for reducing symptoms of post-traumatic stress disorder. The compositions include a combination of an N-methyl-D-aspartate (NMDA) receptor antagonist and an anti-depression agent.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: January 5, 2021
    Assignee: GLYTECH, LLC
    Inventor: Daniel C. Javitt
  • Composition and method for treatment of depression and psychosis in humans
    Patent number: 10660887
    Abstract: Compositions and methods for the treatment of depression and psychoses in humans are disclosed. More particularly, the invention is directed to formulations containing antipsychotic and/or antidepressant medications and also containing an NMDAR antagonist. The present Invention Is also directed to methods tor the treatment of humans suffering from depression and other psychoses, including, schizophrenia, by administration of the inventive compositions in antidepressant and/or antipsychotic effective amounts.
    Type: Grant
    Filed: July 16, 2017
    Date of Patent: May 26, 2020
    Assignee: GLYTECH, LLC
    Inventor: Daniel C. Javitt
  • Composition and method for treatment of depression and psychosis in humans
    Patent number: 10583138
    Abstract: This application relates to combination compositions for use in treatment of depression, and which can alleviate the anxiogenic side effects of certain antidepressant and antipsychotic medications. Methods for treatment of depression and medicament side effects, particular anxiety, akathisia, and associated suicidality are also described herein.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: March 10, 2020
    Assignee: GLYTECH, LLC
    Inventor: Daniel C. Javitt
  • COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS
    Publication number: 20170312275
    Abstract: Compositions and methods for the treatment of depression and psychoses in humans are disclosed. More particularly, the invention is directed to formulations containing antipsychotic and/or antidepressant medications and also containing an NMDAR antagonist. The present Invention Is also directed to methods tor the treatment of humans suffering from depression and other psychoses, including, schizophrenia, by administration of the inventive compositions in antidepressant and/or antipsychotic effective amounts.
    Type: Application
    Filed: July 16, 2017
    Publication date: November 2, 2017
    Applicant: Glytech, LLC
    Inventor: Daniel C. Javitt
  • Composition and method for treatment of depression and psychosis in humans
    Patent number: 9737531
    Abstract: Compositions and methods tor the treatment of depression and psychoses in humans are disclosed. More particularly, the invention is directed to formulations containing antipsychotic and/or antidepressant medications and also containing an NMDAR antagonist. The present invention is also directed to methods for the treatment of humans suffering from depression and other psychoses, including, schizophrenia, by administration of the inventive compositions in antidepressant and/or antipsychotic effective amounts.
    Type: Grant
    Filed: July 7, 2013
    Date of Patent: August 22, 2017
    Assignee: GLYTECH, LLC
    Inventor: Daniel C Javitt
  • COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS
    Publication number: 20150374684
    Abstract: Compositions and methods for the treatment of depression and psychoses in humans are disclosed. More particularly, the invention is directed to formulations containing antipsychotic and/or antidepressant medications and also containing an NMDAR antagonist. The present Invention Is also directed to methods tor the treatment of humans suffering from depression and other psychoses, including, schizophrenia, by administration of the inventive compositions in antidepressant and/or antipsychotic effective amounts.
    Type: Application
    Filed: September 3, 2015
    Publication date: December 31, 2015
    Applicant: GLYTECH, LLC
    Inventor: Daniel C. Javitt